PNV 1.47% $2.07 polynovo limited

Polynovo Channel 7, page-62

  1. 20,346 Posts.
    lightbulb Created with Sketch. 1798
    "To be honest, I don't care much or know much about the science"

    I find it hard to understand why anyone, even you would say some of what you have said, without knowing much about the science?

    For instance, you harped on about BTM and that it should go through a full randomised clinical trial, which they are by the way, via BARDA!

    But it would seem that the management at Polynovo were a lot smarter that Recell management? because they went about things in a much different way and also took another path in tandem?
    They came through to sales via the FDA 510k approval, that to me was smart management, so we not only have a much better product it would seem but also a much better management as well.
    Wasn't that smart management?

    I reckon I might visit AVH soon and tell the readers there that they are on the wrong horse and why?
    Last edited by moosey: 11/10/18
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.07
Change
0.030(1.47%)
Mkt cap ! $1.429B
Open High Low Value Volume
$2.11 $2.12 $2.05 $2.783M 1.335M

Buyers (Bids)

No. Vol. Price($)
5 19976 $2.05
 

Sellers (Offers)

Price($) Vol. No.
$2.07 9633 3
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.